The Biostatistics Center at the George Washington University Milken Institute School of Public Health (Milken Institute SPH) has received an $18.6 million award to continue funding clinical trials and diagnostic studies of antibiotic-resistant infections. The Biostatistics Center serves as the statistical and data management center for the Antibacterial Resistance Leadership Group (ARLG), which is a collaborative clinical research network that prioritizes designs and executes clinical research to combat antibiotic resistance.
Dr. Scott Evans, director of the Biostatistics Center and chair of the Department of Biostatistics and Bioinformatics at Milken Institute SPH, serves as the leader of the statistical and data management center and a member of the executive committee for the ALRG. As the statistical and data management center, the Biostatistics Center collaborates with clinical researchers on the study design, data monitoring, statistical analyses, and the publishing of study results.
“We are delighted to have the opportunity to continue our scientific collaborations with our clinical and laboratory colleagues in the ARLG, which has a key role in research that will ultimately improve the diagnosis, prevention, and treatment of antibiotic resistant infections,” Dr. Evans said. “The numerous scientific challenges in studies of antibiotic resistance accentuates the need for statistical innovation. The Biostatistics Center has a critical leadership role in the ARLG’s research agenda and operations.”Friday Letter Submission, Publish on January 10